Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.45% | 166.93 | 0.7% | $1253.55m | |
| LLY | Eli Lilly & Co. | 0.18% | 311.43 | 1.1% | $814.08m | |
| BMY | Bristol-Myers Squibb Co. | -0.73% | 70.77 | 1.0% | $778.85m | |
| PFE | Pfizer Inc. | -1.10% | 44.08 | 0.9% | $769.71m | |
| ABBV | AbbVie, Inc. | 0.04% | 143.06 | 1.9% | $735.85m | |
| MRK | Merck & Co., Inc. | -0.81% | 86.80 | 0.7% | $691.58m | |
| AZN | AstraZeneca Plc | -3.07% | 54.58 | 1.0% | $397.16m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.95% | 200.78 | 8.2% | $207.03m | |
| NVS | Novartis AG | -1.47% | 76.01 | 0.2% | $201.13m | |
| GBT | Global Blood Therapeutics, Inc. | 0.03% | 67.99 | 5.4% | $199.71m | |
| GSK | GSK Plc | -2.13% | 29.37 | 0.3% | $192.16m | |
| NVO | Novo Nordisk A/S | -0.40% | 97.92 | 0.1% | $170.11m | |
| HZNP | Horizon Therapeutics Plc | 0.54% | 62.97 | 5.4% | $156.21m | |
| SGEN | Seagen Inc. | -0.96% | 139.20 | 5.7% | $152.48m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.42% | 108.19 | 12.4% | $128.76m |
Company Profile
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NC.